Journal of affective disorders

Intravenous ketamine may reduce mental pain in suicidal hospital patients: Analysis of a six-week placebo-controlled trial

Updated

Abstract

No randomized placebo-controlled study has specifically investigated psychological pain as a treatment target in psychiatric populations.

  • Psychological pain may be linked to suicidal thoughts.
  • Ketamine has been studied for its potential effects on psychological pain.
  • The study involved suicidal psychiatric inpatients to assess these effects.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free